Why the study?
Does primary percutaneous coronary intervention (PCI) improve outcomes compared to fibrinolytic therapy in patients with acute myocardial infarction (MI) with ST-segment elevation?
Does primary percutaneous coronary intervention (PCI) improve outcomes compared to fibrinolytic therapy in patients with acute myocardial infarction (MI) with ST-segment elevation?
Primary PCI provides better outcomes than fibrinolytic therapy for STEMI patients, with ongoing efforts to improve access and techniques.
Answers are grounded in this paper and cite their sources.
Supports primary PCI preference in STEMI; leaves open optimal real-world access and implementation strategies.
Patients with acute myocardial infarction (MI) with ST-segment elevation have better outcomes with primary percutaneous coronary intervention (PCI) than with fibrinolytic therapy. Multiple clinical trials in the past 10 years have addressed ways to improve PCI as primary therapy for acute MI. Logistic strategies to improve access to PCI are being studied.
No takes yet. Share an insight, caveat, or question.
Karha et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: